Staff information

PNNL Publications

2024

• Diaz Ludovico I., S.M. Powell, G.M. Many, L.M. Bramer, S. Sarkar, K.G. Stratton, and T. Liu, et al. 2024. "A fast and sensitive size-exclusion chromatography method for plasma extracellular vesicle proteomic analysis." Proteomics 24, no. 16:2400025. PNNL-SA-194254. doi:10.1002/pmic.202400025
• Sarkar S., C. Dieter, J.E. Kyle, M. Guney, D. Sarbaugh, R. Yin, and X. Li, et al. 2024. "Regulation of ß-cell death by ADP-ribosylhydrolase ARH3 via lipid signaling in insulitis." Cell Communication and Signaling 22, no. _:141. PNNL-SA-152364. doi:10.1101/2020.03.23.004481
• Sarkar S., X. Zheng, G. Clair, Y. Kwon, Y. You, A.C. Swensen, and B.M. Webb-Robertson, et al. 2024. "Exploring new frontiers in type 1 diabetes through advanced mass-spectrometry-based molecular measurements." Trends in Molecular Medicine 30, no. 12:1137-1151. PNNL-SA-198900. doi:10.1016/j.molmed.2024.07.009
• You Y., S. Sarkar, C. Deiter, E.C. Elliott, C.D. Nicora, R.G. Mirmira, and L. Sussel, et al. 2024. "Reduction of chemokine CXCL9 expression by omega-3 fatty acids via ADP-ribosylhydrolase ARH3 in MIN6 insulin-producing cells." Proteomics 25, no. 3:Art No. e202400053. PNNL-SA-206213. doi:10.1002/pmic.202400053

2023

• Diaz Ludovico I., S. Sarkar, E.C. Elliott, S.M. Virtanen, I. Erlund, S. Ramanadham, and R.G. Mirmira, et al. 2023. "Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies." Expert Opinion on Therapeutic Targets 27, no. 9:793-806. PNNL-SA-185489. doi:10.1080/14728222.2023.2259099
• Sarkar S., E.C. Elliott, H.R. Henry, I. Diaz Ludovico, J.T. Melchior, A. Frazer-Abel, and B.M. Webb-Robertson, et al. 2023. "Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism and immune response." Clinical Proteomics 20. PNNL-ACT-SA-10706. doi:10.1186/s12014-023-09429-6
• Sims E.K., A. Kulkarni, A. Hull, S. Woerner, S. Cabrera, L. Mastrandrea, and B. Hammoud, et al. 2023. "Inhibition of polyamine biosynthesis preserves ß cell function in type 1 diabetes." Cell Reports Medicine 4, no. 11:Art. No. 101261. PNNL-SA-194634. doi:10.1016/j.xcrm.2023.101261
• Vallejo M.C., S. Sarkar, E.C. Elliott, H.R. Henry, S.M. Powell, I. Diaz Ludovico, and Y. You, et al. 2023. "A proteomic meta-analysis refinement of plasma extracellular vesicles." Scientific Data 10. PNNL-SA-178237. doi:10.1038/s41597-023-02748-1
• You Y., C. Tsai, R. Patel, S. Sarkar, G. Clair, M. Zhou, and T. Liu, et al. 2023. "Analysis of a macrophage carbamylated proteome reveals a function in post-translational modification crosstalk." Cell Communication and Signaling 21, no. 1:241. PNNL-SA-186292. doi:10.1186/s12964-023-01257-3

2022

• Aguirre R., A. Kulkarni, M.W. Becker, X. Lei, S. Sarkar, S. Ramanadham, and E. Phelps, et al. 2022. "Extracellular Vesicles in ß Cell Biology: Role of Lipids in Vesicle Biogenesis, Cargo, and Intercellular Signaling." Molecular Metabolism 63. PNNL-SA-173821. doi:10.1016/j.molmet.2022.101545
• Sarkar S., J.T. Melchior, H.R. Henry, F. Syed, R.G. Mirmira, E.S. Nakayasu, and T.O. Metz. 2022. "GDF15: a potential therapeutic target for type 1 diabetes." Expert Opinion on Therapeutic Targets 26, no. 1:57 - 67. PNNL-SA-168207. doi:10.1080/14728222.2022.2029410